SNDX - Syndax Pharmaceuticals Inc
IEX Last Trade
12.74
-0.010 -0.078%
Share volume: 67,664
Last Updated: Fri 27 Dec 2024 08:29:55 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$12.75
-0.01
-0.08%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-09 | 2022-08-08 | 2022-11-03 | |
| Assets | ||||
| Total Assets | 422.222 M | 406.437 M | 359.687 M | |
| Current Assets | 420.056 M | 392.287 M | 357.631 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 9.032 M | 15.494 M | 6.808 M | |
| Short Term Investments | 9.032 M | 15.494 M | 6.808 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 410.909 M | 376.678 M | 350.708 M | |
| Total Non-current Assets | 2.166 M | 14.150 M | 2.056 M | |
| Property Plant Equipment | 266.000 K | 256.000 K | 23.000 K | |
| Other Assets | 1.027 M | 995.000 K | 881.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 422.222 M | 406.437 M | 359.687 M | |
| Total liabilities | 47.672 M | 44.497 M | 21.585 M | |
| Total current liabilities | 30.550 M | 30.925 M | 20.803 M | |
| Accounts Payable | 8.231 M | 6.438 M | 7.115 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 3.568 M | 7.214 M | 4.000 K | |
| Long term debt | 16.479 M | 13.002 M | 14.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 374.549 M | 361.940 M | 338.102 M | |
| Common stock | 58.979 M | 60.157 M | 60.670 M | |
| Retained earnings | -580.871 M | -618.443 M | -653.846 M |